Financials in GBp. Standardized financial statements.
A compact view of how Beximco Pharmaceuticals Limited turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £44.39B | £39.27B | £34.67B | £29.49B | £25.61B | £22.82B | £17.72B | £15.51B | £12.97B | £11.21B |
| Revenue Growth? | +13.1% | +13.3% | +17.5% | +15.2% | +12.3% | +28.8% | +14.2% | +19.6% | +15.7% | 0.0% |
| Cost of Revenue? | £24.76B | £22.16B | £18.85B | £15.57B | £13.71B | £12.20B | £9.43B | £8.32B | £6.97B | £6.10B |
| Gross Profit? | £19.63B | £17.10B | £15.81B | £13.92B | £11.90B | £10.62B | £8.29B | £7.18B | £6.00B | £5.10B |
| Gross Margin? | +44.2% | +43.6% | +45.6% | +47.2% | +46.5% | +46.5% | +46.8% | +46.3% | +46.3% | +45.5% |
| Operating Expenses? | £10.96B | £9.90B | £8.94B | £7.17B | £6.53B | £5.76B | £4.43B | £3.88B | £3.27B | £2.79B |
| Operating Income? | £8.67B | £7.22B | £6.90B | £6.65B | £5.61B | £5.07B | £4.03B | £3.45B | £2.85B | £2.42B |
| EBITDA? | £10.64B | £9.37B | £8.25B | £7.39B | £5.83B | £5.13B | £4.72B | £3.53B | £3.10B | £2.90B |
| Income Before Tax | £7.53B | £6.07B | £6.69B | £6.38B | £4.65B | £3.95B | £3.36B | £2.89B | £2.34B | £2.11B |
| Income Tax Expense | £1.66B | £1.54B | £1.69B | £1.21B | £1.11B | £905.66M | £828.68M | £664.79M | £382.85M | £581.26M |
| Net Income? | £5.83B | £4.61B | £5.12B | £5.13B | £3.51B | £3.03B | £2.54B | £2.23B | £1.95B | £1.53B |
| EPS? | £13.07 | £10.34 | £11.48 | £11.49 | £7.88 | £6.80 | £5.69 | £4.99 | £4.38 | £3.43 |
| Diluted EPS? | £13.07 | £10.34 | £11.48 | £11.49 | £7.88 | £6.80 | £5.69 | £4.99 | £4.38 | £3.43 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality